Revenue grew 9.6% to ₹6,409 Crores and PAT rose 17.8% to ₹1,414 Crores, with strong growth in Gastroenterology and new product launches. Dividend increased to ₹475 per share, and return on capital employed reached 35.7%.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.